Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Vidal

Showing results (71-80 of 123) with videos related to

Pageof 13
Sort By:
Neuroimage. Clinical|February 24, 2022
T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associationsMateus Boaventura, Jaume Sastre-Garriga, Aran Garcia-Vidal, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 4, 2026
A case of myelopathy due to HTLV-1 infectionMaider Iza-Achutegui, Luca Bollo, Jordi Rio, et al.
Neuroimage. Clinical|September 20, 2022
Detection of lesions in the optic nerve with magnetic resonance imaging using a 3D convolutional neural networkGerard Martí-Juan, Marcos Frías, Aran Garcia-Vidal, et al.
Frontiers in Neurology|April 26, 2021
Deciphering Multiple Sclerosis ProgressionVirginia Meca-Lallana, Leticia Berenguer-Ruiz, Joan Carreres-Polo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2017
Characteristics of morphologic macular abnormalities in neuroimmunology practiceOmar Al-Louzi, Elias S Sotirchos, Angela Vidal-Jordana, et al.
Revista De Neurologia|June 11, 2014
Biomarkers in multiple sclerosis: an update for 2014Oscar Fernandez, Roland Martin, Alex Rovira, et al.
The Lancet. Neurology|September 20, 2025
The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosisShiv Saidha, Ari J Green, Letizia Leocani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 16, 2013
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changesAngela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2012
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decisionCarmen Tur, Mar Tintoré, Angela Vidal-Jordana, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2021
Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patientsAlex Rovira, Juan Francisco Corral, Cristina Auger, et al.
Pageof 13

Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
Neuroimage. Clinical|February 24, 2022
T1/T2-weighted ratio in multiple sclerosis: A longitudinal study with clinical associationsMateus Boaventura, Jaume Sastre-Garriga, Aran Garcia-Vidal, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 4, 2026
A case of myelopathy due to HTLV-1 infectionMaider Iza-Achutegui, Luca Bollo, Jordi Rio, et al.
Neuroimage. Clinical|September 20, 2022
Detection of lesions in the optic nerve with magnetic resonance imaging using a 3D convolutional neural networkGerard Martí-Juan, Marcos Frías, Aran Garcia-Vidal, et al.
Frontiers in Neurology|April 26, 2021
Deciphering Multiple Sclerosis ProgressionVirginia Meca-Lallana, Leticia Berenguer-Ruiz, Joan Carreres-Polo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2017
Characteristics of morphologic macular abnormalities in neuroimmunology practiceOmar Al-Louzi, Elias S Sotirchos, Angela Vidal-Jordana, et al.
Revista De Neurologia|June 11, 2014
Biomarkers in multiple sclerosis: an update for 2014Oscar Fernandez, Roland Martin, Alex Rovira, et al.
The Lancet. Neurology|September 20, 2025
The use of optical coherence tomography and visual evoked potentials in the 2024 McDonald diagnostic criteria for multiple sclerosisShiv Saidha, Ari J Green, Letizia Leocani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 16, 2013
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changesAngela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2012
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decisionCarmen Tur, Mar Tintoré, Angela Vidal-Jordana, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 3, 2021
Assessment of automatic decision-support systems for detecting active T2 lesions in multiple sclerosis patientsAlex Rovira, Juan Francisco Corral, Cristina Auger, et al.
Pageof 13